Giant-cell myocarditis is a fatal autoimmune disorder that is often associated with other autoimmune diseases. We herein describe a case of giant-cell myocarditis complicated by heparin-induced thrombocytopenia (HIT). A 71-year-old woman was admitted to our hospital due to palpitations and ptosis. Echocardiography revealed hypokinesis in the left basal ventricular walls. Heart failure gradually developed, and the condition was complicated by HIT. The patient died of cardiogenic and septic shock caused by agranulocytosis. An autopsy showed giant-cell myocarditis. When severe left ventricular dysfunction due to an unknown cause is complicated by HIT, potential diagnoses of giant-cell and other types of autoimmune myocarditis should thus be investigated.
Introduction
Giant-cell myocarditis is a rare and fatal disorder of autoimmune origin that is often complicated by other autoimmune diseases such as ulcerative colitis, Crohn's disease, Hashimoto's disease and myasthenia gravis (1, 2) . We herein describe a case of giant-cell myocarditis complicated by heparin-induced thrombocytopenia (HIT).
Case Report
A 71-year-old woman presented to the emergency department with palpitations and ptosis. These symptoms had persisted for seven days prior to admission. On examination, she was alert and oriented. Her blood pressure was 118/70 mmHg, her body temperature was 37 , her heart rate was 91 beats per minute, her respiratory rate was 17 breaths per minute and her oxygen saturation was 100% while she breathed ambient air. Her breath sounds and heart sounds were normal. Neurologically, mild bilateral muscle weakness was observed in the upper limbs and ptosis was observed in the left eyelid. Electrocardiogram showed third degree atrioventricular block with a ventricular rate of 90 beats per minute. Although electrocardiogram also showed STsegment elevation in the V1-4 leads, it was non-diagnostic due to the presence of ventricular escape rhythms (Fig. 1A) . Echocardiography revealed that, while the left ventricle was of normal size, its basal inferior, posterior, lateral and anterior walls were hypokinetic. The estimated left ventricular ejection fraction was 44%. The septal and left ventricular posterior wall thicknesses were 9 mm each, thus indicating an absence of any apparent left ventricular hypertrophy or edema. There were mild mitral and tricuspid valve regurgitations; however, no apparent intra-cardiac thrombi were observed. Chest radiographs showed mild cardiomegaly without congestion (Fig. 1B) . The patient was admitted to our hospital with these symptoms.
Coronary angiography showed normal coronary arteries, and temporary cardiac pacing was initiated. The results of the laboratory tests are shown in Table. The patient had been healthy until the manifestation of palpitations and pto- sis. She had undergone appendectomy in the past. She had never smoked, did not drink alcohol and took no medications. The plasma CRP level was 5.44 mg/dL and the plasma CPK and CPK-MB levels were mildly elevated (279 IU/L and CK-MB 14.6 IU/L, respectively). The differential diagnosis was thought to include myocarditis, sarcoidosis, collagen disease and other secondary cardiomyopathies. The patient was closely observed during bed rest, temporary cardiac pacing and intravenous unfractionated heparin administered to prevent left ventricular thrombi. The anticoagulant effect of heparin was monitored according to the activated coagulation time, and the heparin dose was titrated to maintain an activated coagulation time between 160 and 180 seconds. The maintenance dose of heparin was 9,000 units per day. Although the patient remained hemodynamically stable, her mild general fatigue and ptosis persisted. She was referred for consultation with a neurologist. A repetitive stimulation test was performed; however, there were no significant findings. Tests for serum anti-acetylcholine receptor antibodies were negative. A computed tomography (CT) scan obtained on the fifth day of admission showed no masses in the mediastinum, thereby negating the presence of thymoma. The cause of the neurological abnormalities thus remained unclear.
On the seventh day, the patient's urine output decreased and her BNP level became elevated. Treatment with furosemide and angiotensin-converting enzyme inhibitor was begun. On the 12th day, as hypotension developed, the patient was transferred to the coronary intensive care unit. Treatment with milrinone was initiated and a Swan-Ganz catheter was inserted. Due to the disappearance of the atrioventricular block, temporary cardiac pacing was discontinued. Thrombocytopenia progressively developed and a blood sample for heparin antibodies was obtained. On the 19th day, heparin treatment was replaced with argatroban treatment because a diagnosis of HIT was suspected. On the 20th day, tests for heparin antibodies were positive and the diagnosis of HIT was confirmed. The thrombocytopenia rap- idly improved; however, a CT scan performed on the 21st day showed multiple thrombi in the right ventricle and right jugular vein in which the Swan-Ganz catheter was placed. Echocardiograms revealed gradual deterioration of the left ventricular wall motion. The estimated left ventricular ejection fraction fell to 23%. On the 23rd day, the patient's blood pressure fell to 60/40 mmHg and she became stuporous. Treatment with norepinephrine by intravenous infusion was initiated and the trachea was intubated. An intra-aortic balloon pump was introduced, after which the patient's vital signs stabilized. Norepinephrine was discontinued. On the 26th day, an endomyocardial biopsy of the left ventricle was performed. On the 27th day, the inflammatory findings noticeably worsened after the occurrence of pneumonia. Pazufloxacin was initiated intravenously. On the 30th day, the findings of the myocardial biopsy were reported, which showed marked infiltration of inflammatory cells into the myocardium, severe myocyte loss and replacement fibrosis. A large majority of the inflammatory cells were lymphocytes, suggesting a diagnosis of fulminant-type lymphocytic myocarditis (Fig. 2) . On the 33rd day, agranulocytosis developed and a high fever appeared. A CT scan performed on that day revealed massive bilateral pneumonia, and the hypoxia severely worsened. Meropenem and human recombinant granulocyte colony-stimulating factor were administered. Subsequently, sudden cardiac arrest occurred. A heartbeat was resumed through cardiopulmonary resuscitation and a single intravenous injection of adrenaline. As the hypotension persisted, percutaneous cardiopulmonary support was introduced and high-dose intravenous noradrenaline was initiated. Acidosis and hypotension persisted despite increasing doses of vasopressors, and the patient died 34 days after admission to the hospital.
An autopsy was performed. The heart weighed 480 grams. A cross-section of the heart revealed the right ventricular thrombus that had been diagnosed on CT and echocardiography (Fig. 3A) . Microscopic examinations of the autopsied myocardium showed a severe degree of diffuse myocyte loss, replacement fibrosis and infiltration of inflammatory cells that were primarily lymphocytes ( Fig. 3B-D) . At higher magnifications, multinucleated giant cells were observed in a characteristic nested pattern without granulomas (Fig. 3C, D) , indicating giant-cell myocarditis. Asteroid bodies were observed in the cytoplasm of these giant cells.
Although pathological examinations of both lungs showed numerous nests of bacteria, there was a poor response of granulocytes to the infection. A microscopic analysis of the bone marrow revealed very few myeloid cells, suggesting agranulocytosis. An analysis of the iliopsoas muscle obtained at the autopsy showed small, angulated fibers and group atrophy, suggesting neurogenic degeneration of the muscles. There was neither lymphadenopathy nor histological evidence of noncaseating granulomas in the lungs, liver, spleen, muscles or bone marrow and no masses were found in the mediastinum. Based on these findings, final diagnoses of giant-cell myocarditis, severe pneumonia and sepsis complicated by agranulocytosis were made.
Discussion
The present report describes a rare case of giant-cell myocarditis complicated by HIT. Only two cases of giant-cell myocarditis complicated by HIT have been previously reported (3, 4). Schenk and coauthors reported a case of giantcell myocarditis complicated by HIT occurring after total artificial heart implantation (3). That patient subsequently underwent heart transplantation and exhibited relatively mild HIT with no thromboembolic events. Alekshun and coauthors reported a case of giant-cell myocarditis complicated by HIT occuring after biventricular assist device placement (4). Both propagating clots developed in the biventricular assist device and thrombocytopenia improved after the administration of bivalirudin. However, the patient died of multiorgan failure related to giant-cell myocarditis. HIT is considered to be a drug-associated autoimmune disease (5). The immunogen is a coagulation active complex of heparin and platelet factor 4 (5). The outcomes of the present case and the above two cases suggest that both HIT and giant-cell myocarditis are induced by common immunological abnormalities in self-antigens. A recent report showed that autoimmune diseases and the administration of full anticoagulation doses of unfractionated heparin may be risk factors for HIT (6) . Accordingly, when severe left ventricular dysfunction due to an unknown cause is complicated by HIT, giant-cell and other types of autoimmune myocarditis should be examined as possible diagnoses. In addition, the use of low-molecular-weight heparin, but not unfractionated heparin, should be considered for anticoagulant therapy in patients suspected of having autoimmune myocarditis, including giant-cell myocarditis.
We initially suspected that the patient's diagnosis was giant-cell myocarditis complicated by myasthenia gravis. However, immunological and neurological examinations, i.e., tests for serum anti-acetylcholine receptor antibodies and the repetitive nerve stimulation test, did not suggest a diagnosis of myasthenia gravis. Iwanami et al. have shown that repetitive nerve stimulation tests are positive in only 47% of generalized myasthenia gravis and ocular myasthenia gravis patients (7) . Furthermore, approximately 12% of patients with generalized myasthenia gravis have neither acetylcholine receptor antibodies nor muscle-specific kinase antibodies (8) . The edrophonium test is helpful for the diagnosis of this disease; however, it was not performed in the present case because of the patient's poor general condition.
Therefore, we cannot deny the possibility of sero-negative myasthenia gravis in this case.
It has been shown that immunosuppressive therapy may be effective for the treatment of giant-cell myocarditis (9); therefore, prompt diagnosis is necessary. In the present case, one may argue that the endomyocardial biopsy should have been performed earlier. However, it has been reported that the complication rate of endomyocardial biopsies is between 1.6% and 6.0%, indicating a relatively high risk associated with this procedure (10-13). In particular, performing an endomyocardial biopsy in the acute phase of myocarditis may be associated with higher risks, since the procedure is sometimes complicated by ventricular perforation of edematous myocardium, fatal arrhythmia and other fatal incidents. In contrast, the most recent study showed that the major complication rate for left ventricular endomyocardial biopsies is 0.64% and that for right ventricular endomyocardial biopsies is 0.82%, thus indicating a lower risk compared with previous reports (14) . The recently published guidelines of the American Heart Association, the American College of Cardiology and the European Society of Cardiology state that new-onset heart failure of two weeks duration associated with a normal-sized or dilated left ventricle and hemodynamic compromise is a class I indication for a left ventricular endomyocardial biopsy (15) . In the present case, the patient's vital signs were stable during the early phase of the clinical course, and after the hemodynamic compromise occurred, performing an endomyocardial biopsy was of considerable risk due to severe thrombocytopenia. Therefore, an endomyocardial biopsy could not have been performed in the early phase of the disease. Moreover, the samples of the endomyocardial biopsy indicated lymphocytic myocarditis, thus demonstrating another problem with endomyocardial biopsies. The present case suggests that several samples should be obtained from the bi-ventricles and numerous slices should be cut from fixed samples.
The differential diagnosis of the present case included sarcoidosis. Complete atrioventricular block and cardiomyopathy suggested the possibility of cardiac sarcoidosis. However, several findings were atypical for sarcoidosis. First, there were no sarcoid lesions in other organs. Second, there were no typical epithelioid granulomas. Third, giant cells were primarily observed in necrotic myocardium. These findings all imply a diagnosis of giant-cell myocarditis.
We herein report a case of giant-cell myocarditis complicated by HIT. When severe left ventricular dysfunction due to an unknown cause is complicated by HIT, diagnoses of giant-cell and other types of autoimmune myocarditis should therefore be investigated.
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